CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 322,907 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,000 shares at $4.59 ($9,180)
- 4 Insider Changes in Ownership
- 4 Other acquisition 10% owner acquired 2,069,993 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition 10% owner acquired 663,346 shares (other)
- 4 Other acquisition 10% owner acquired 14,449 shares (other)
- 4 Other acquisition 10% owner acquired 720,878 shares (other)
Page 15 of 34 · 675 filings